Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
ABL Diagnostics
Acquired Company
IntegraGen
Grand EstFranceBiotechnologyBiotechnologyHealth CareGeneticsBioinformaticsDescription
ABL Texcell Diagnostics has officially acquired the assets and business operations of IntegraGen. This acquisition follows a court ruling and aims to strengthen ABL Texcell's presence in precision oncology. The move underscores ABL Texcell's commitment to advancing molecular diagnostics. The acquisition is expected to enhance development in biopharmaceutical solutions.
Fundz sees it the moment ABL Diagnostics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired IntegraGen?
IntegraGen was acquired by ABL Diagnostics, based in Grand Est. The deal was reported on October 12, 2026. ABL Diagnostics is an international company specializing in innovative molecular biology tests. It offers solutions in molecular detection and genotyping services. ABL Diagnostics is privately held and operates in Biotechnology.
When did ABL Diagnostics acquire IntegraGen?
ABL Diagnostics's acquisition of IntegraGen was reported on October 12, 2026. ABL Texcell Diagnostics has officially acquired the assets and business operations of IntegraGen. This acquisition follows a court ruling and aims to strengthen ABL Texcell's presence in precision oncology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does IntegraGen do?
IntegraGen is a company within the OncoDNA Group specializing in cancer genomics and rare genetic diseases. It leverages highly qualified and experienced teams to provide major services in DNA sequencing and genomic data interpretation software. It is privately held, operating in Biotechnology, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.